Vertex Pharmaceuticals (Poland)sp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-12-08
Share capital
5,000.00 PLN
Registered address
ul. Ludwika Waryńskiego 3A, 00-645 Warszawa, Poland
Electronic delivery address
AE:PL-71346-32324-EDFEG-12

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 154 days late).

  • 202514/05/2026
  • 202410/06/2025
  • 202304/06/2024
  • 202209/06/2023
  • 202116/12/2022
  • 202004/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 5.75mMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD 278.12kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 5.34mMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 2.69mMedianUSD 897.46kAverageUSD 31.52m

Authorized Representatives

Ulrich Stefan Lentzer – Management Board Member
Marek Michał Macyszyn – Attorney-in-fact (sole)
Omar White – Management Board Member
Prasanna Thombre – Management Board Member
Trent Townsend – Management Board Member

Manner of representation

Each member of the management board is entitled to independently represent the company.

Ownership

OwnerSharesShare valueStake
Vertex Pharmaceuticals (europe) Limited
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-02-08.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Change history

DateEvent
2020-03-12Address change
2017-12-08Entered in the register

FAQ

Last updated: 2026-10-07